<?xml version="1.0" encoding="UTF-8"?>
<OAI-PMH xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd">
  <responseDate>2024-04-29T00:45:06Z</responseDate>
  <request verb="GetRecord" identifier="oai:pubmedcentral.nih.gov:6441605" metadataPrefix="pmc">https:/www.ncbi.nlm.nih.gov/pmc/oai/oai.cgi</request>
  <GetRecord>
    <record>
      <header>
        <identifier>oai:pubmedcentral.nih.gov:6441605</identifier>
        <datestamp>2019-04-04</datestamp>
        <setSpec>medoral</setSpec>
        <setSpec>pmc-open</setSpec>
      </header>
      <metadata>
        <article xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xsi:schemaLocation="https://jats.nlm.nih.gov/ns/archiving/1.3/ https://jats.nlm.nih.gov/archiving/1.3/xsd/JATS-archivearticle1-3.xsd" article-type="research-article">
          <front>
            <journal-meta>
              <journal-id journal-id-type="nlm-ta">Med Oral Patol Oral Cir Bucal</journal-id>
              <journal-id journal-id-type="iso-abbrev">Med Oral Patol Oral Cir Bucal</journal-id>
              <journal-id journal-id-type="publisher-id">Medicina Oral S.L.</journal-id>
              <journal-title-group>
                <journal-title>Medicina Oral, Patología Oral y Cirugía Bucal</journal-title>
              </journal-title-group>
              <issn pub-type="ppub">1698-4447</issn>
              <issn pub-type="epub">1698-6946</issn>
              <publisher>
                <publisher-name>Medicina Oral S.L.</publisher-name>
              </publisher>
            </journal-meta>
            <article-meta>
              <article-id pub-id-type="accession">PMC6441605</article-id>
              <article-id pub-id-type="pmcid">PMC6441605</article-id>
              <article-id pub-id-type="pmc-uid">6441605</article-id>
              <article-id pub-id-type="pmid">30818311</article-id>
              <article-id pub-id-type="pmid">30818311</article-id>
              <article-id pub-id-type="publisher-id">22699</article-id>
              <article-id pub-id-type="doi">10.4317/medoral.22699</article-id>
              <article-categories>
                <subj-group subj-group-type="heading">
                  <subject>Research</subject>
                  <subj-group>
                    <subject>Medically compromised patients in Dentistry</subject>
                  </subj-group>
                </subj-group>
              </article-categories>
              <title-group>
                <article-title>Effectiveness of a spray containing 1% malic acid in patients with xerostomia induced by graft-versus-host disease</article-title>
              </title-group>
              <contrib-group>
                <contrib contrib-type="author" corresp="yes">
                  <name>
                    <surname>Bardellini</surname>
                    <given-names>Elena</given-names>
                  </name>
                  <xref ref-type="aff" rid="A1">1</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Amadori</surname>
                    <given-names>Francesca</given-names>
                  </name>
                  <xref ref-type="aff" rid="A2">2</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Conti</surname>
                    <given-names>Giulio</given-names>
                  </name>
                  <xref ref-type="aff" rid="A3">3</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Veneri</surname>
                    <given-names>Federica</given-names>
                  </name>
                  <xref ref-type="aff" rid="A4">4</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Majorana</surname>
                    <given-names>Alessandra</given-names>
                  </name>
                  <xref ref-type="aff" rid="A5">5</xref>
                </contrib>
              </contrib-group>
              <aff id="A1"><label>1</label>AP, DDS, MS. Department of Pediatric Dentistry, Dental Clinic, University of Brescia Brescia, Italy</aff>
              <aff id="A2"><label>2</label>DDS PhD. Department of Pediatric Dentistry, Dental Clinic, University of Brescia Brescia, Italy</aff>
              <aff id="A3"><label>3</label>DDS, MS, PhD University of Milan, Milan, Italy</aff>
              <aff id="A4"><label>4</label>DDS. Department of Pediatric Dentistry, Dental Clinic, University of Brescia Brescia, Italy</aff>
              <aff id="A5"><label>5</label>FP, DDS, MS. Department of Pediatric Dentistry, Dental Clinic, University of Brescia Brescia, Italy</aff>
              <author-notes>
                <corresp> Dental Clinic, p.le Spedali Civili n.1, 25133 Brescia, Italy
, E-mail: <email>elena.bardellini@unibs.it</email></corresp>
                <fn id="FN1" fn-type="COI-statement">
                  <p><bold>Conflict of interest statement:</bold>The Authors disclose any financial and personal relationships with other people or organisations that could inappropriately influence their work.</p>
                </fn>
              </author-notes>
              <pub-date pub-type="ppub">
                <month>3</month>
                <year>2019</year>
              </pub-date>
              <volume>24</volume>
              <issue>2</issue>
              <fpage>e190</fpage>
              <lpage>e194</lpage>
              <history>
                <date date-type="accepted">
                  <day>7</day>
                  <month>1</month>
                  <year>2019</year>
                </date>
                <date date-type="received">
                  <day>9</day>
                  <month>8</month>
                  <year>2018</year>
                </date>
              </history>
              <permissions>
                <copyright-statement>Copyright: © 2019 Medicina Oral S.L.</copyright-statement>
                <copyright-year>2019</copyright-year>
                <license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/2.5/">
                  <license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p>
                </license>
              </permissions>
              <abstract>
                <sec>
                  <title>Background</title>
                  <p>To evaluate the clinical effectiveness of a topical sialogogue spray (malic acid, 1%) in the treatment of xerostomia in patients with chronic Graft versus Host Disease (cGVHD).</p>
                </sec>
                <sec>
                  <title>Material and Methods</title>
                  <p>This study was designed as a randomized double-blind clinical study. Twenty-eight patients with cGVHD suffering from xerostomia were divided into 2 groups: the first group (14 patients) received a topical sialagogue spray containing malic acid 1% (SalivAktive®) whereas the second group (14 patients) received a placebo. Both groups received treatment for 2 weeks. Dry Mouth Questionnaire (DMQ) scores and unstimulated salivary flows rate were collected before and after treatment.</p>
                </sec>
                <sec>
                  <title>Results</title>
                  <p>DMQ scores increased significantly from 1.3 ± 0.4 to 3.5 ± 0.4 points (<italic>p</italic> &lt;0.05) after two weeks of treatment with malic acid, whereas in the control group DMQ scores increased from 1.2 ± 0.7 points to 1.4 ± 0.6 (<italic>p</italic> &gt;0.05). The unstimulated salivary flow rate in patients treated with malic acid increased significantly from 0.15 ± 0.06 mL/min to 0.24± 0.08 mL/min, while that of the patients treated with placebo went from 0.16 ± 0.07 mL/min to 0.17 ± 0.09 mL/min (<italic>p</italic> &gt;0.05).</p>
                </sec>
                <sec>
                  <title>Conclusions</title>
                  <p>Malic acid 1% spray can be considered effective in the treatment of GVHD induced xerostomia.</p>
                  <p><bold> Key words:</bold>Xerostomia, malic acid, transplantation.</p>
                </sec>
              </abstract>
            </article-meta>
          </front>
          <body>
            <sec>
              <title>Introduction</title>
              <p>Graft versus host disease (GVHD) is one of the most frequent and serious complications of hematopoietic stem cell transplantation. After transplantation, the donor’s T lymphocytes may recognize the antigens expressed by the re¬cipient’s cells as foreign, inducing an immune reaction accompanied by intense inflammatory responses. The acute presentation of GVHD typically affects the skin, the gastrointestinal tract, and the liver. The chronic form is characterized by the involvement of several organs, including the oral cavity, which could represent the primary site of chronic GVHD (cGVHD) (<xref rid="B1" ref-type="bibr">1</xref>-<xref rid="B3" ref-type="bibr">3</xref>).</p>
              <p>The prevalence of oral cGVHD ranges between 45-83%; moreover, the oral cavity could be the only affected body region (<xref rid="B4" ref-type="bibr">4</xref>-<xref rid="B5" ref-type="bibr">5</xref>). The specific or distinctive clinical oral features comprise oral lichenoid lesions, hyperkeratotic plaques, mucosal atrophy, erythema, ulcers, pseudomembranes, limited oral aperture secondary to sclerosis and, last but not least, xerostomia.</p>
              <p>Xerostomia can manifest itself with some frequency as a consequence of progressive salivary gland damage. Salivary gland dysfunction in cGVHD patients mimics Sjögren syndrome; it is characterized by histopathological changes, consisting of mononuclear infiltration with periductal infiltration, and/or atrophy of salivary gland lobules and peri-glandular fibrosis (<xref rid="B6" ref-type="bibr">6</xref>). Recent studies reported that saliva in patients with cGVHD have significantly higher concentrations of sodium, magnesium, epidermal growth factor, total protein, albumin and immunogoblin G (<xref rid="B7" ref-type="bibr">7</xref>). As a result of the histopathological changes and of the altered salivary concentrations, the functional capacities of saliva (i.e. chemical digestion; lubrification and cleaning; pH buffering effect; anti-inflammatory, anti-bacterial and anti-viral activity) are impaired. The repercussions are a disruption of the mucosal integrity, insufficient protection against mechanical and chemical epithelial injuries, and reduced anti-cariogenic activity (<xref rid="B7" ref-type="bibr">7</xref>). Furthermore, a dry mouth can compromise swallowing, speaking, and sleeping; this, in turn, is associated to a worsening of a patient’s quality of life referred to the oral cavity and due to a diminished body mass index (<xref rid="B8" ref-type="bibr">8</xref>).</p>
              <p>Although no standard treatment guidelines are available, many treatment options exist for the management of xerostomia and hypo-salivation, from topical agents to systemic therapies. Intraoral topical agents, being free of side effects, are among the most commonly recommended treatments for the management of xeros¬tomia. The purpose of this study was to evaluate the effectiveness of a topical sialogogue spray containing malic acid 1% (Salivaktive®) in patients with cGVHD experiencing xerostomia.</p>
            </sec>
            <sec>
              <title>Material and Methods</title>
              <p>-Study population</p>
              <p>Thirty-one consecutive patients were enrolled. Inclusion criteria were transplanted subjects who developed cGVHD and dryness in the mouth. Exclusion criteria were head-neck radiation therapy, Sjogren’s syndrome and/or related autoimmune diseases (rheumatoid arthritis, polyarthritis nodosa, systemic sclerosis or lupus erythematosus), diabetes, current xerostomic medication (anti-hypertensives, anti-depressants, anxiolytics, anti-psychotics, anti-cholinergics, adrenergic blockers, anti-asthmatics), smoking and chronic alcohol abuse.</p>
              <p>-Study design</p>
              <p>This study was designed as a randomized controlled clinical study. Sample size was based on the standard deviation of the main variable: Dry Mouth Questionnaire (DMQ). A pilot sample of 10 patients was tested to determine the minimum sample size necessary to reliably confirm the hypothesis that a topical 1% malic acid sialogogue spray is effective in treating xerostomia induced by cGVHD over a 2 weeks period.</p>
              <p>The patients were randomly assigned to two groups. Randomization was performed using an automatically generated list in a 1:1 block size for two patients. The patients included received a number and were randomly assigned to one of the two sprays by a member of the team who performed a permuted-block randomization of the participants. Patients codes where inserted into closed envelopes.</p>
              <p>The patients were randomized by a computer code into two groups: group A, who received a topical sialogogue spray (malic acid, 1%) and group B, who received a placebo (i.e. saline solution).</p>
              <p>The two products shared the same packaging. The sprays were applied four times a day. Both patients and researchers were blinded throughout the study.</p>
              <p>Dry mouth questionnaire (DMQ)</p>
              <p>The DMQ was used to assess the severity of dry mouth before and after treatment with malic acid/placebo. (<xref rid="B9" ref-type="bibr">9</xref>-<xref rid="B11" ref-type="bibr">11</xref>) Every patient answered the DMQ before receiving a spray (1% malic acid or placebo) and after 2 weeks of use. Increased DMQ scores indicate improvement of dry mouth. The DMQ used a 0-to-4 rating scale where 0= very dry and 4=not dry at all (<xref rid="T1" ref-type="table"> Table 1</xref>).</p>
              <p>
                <table-wrap id="T1" orientation="portrait" position="float">
                  <label>Table 1</label>
                  <caption>
                    <title>Dry Mouth Questionnaire (DMQ).</title>
                  </caption>
                  <graphic xlink:href="medoral-24-e190-t001"/>
                </table-wrap>
              </p>
              <p>-Sialometries</p>
              <p>The unstimulated salivary flow rate was obtained by the spit method every 30s for 15 minutes. Saliva was collected in 20-mL plastic containers. Measurements were expressed as millilitre per minute (<xref rid="B13" ref-type="bibr">13</xref>).</p>
              <p>-Statistical Analysis</p>
              <p>The main purpose was to contrast different DMQ scores at T0 and T1 by using the Mann-Whitney U- test. A 5% significance level was used for the analysis. Student’s t-test was used to analyse unstimulated salivary flow rate </p>
              <p>-Ethical Considerations</p>
              <p>The research was performed in compliance with the Declaration of Helsinki and Good Clinical Practice. All patients were informed about the research and signed an IRB approved informed consent. Ethical approval for the research was granted by the local Ethic Committee.</p>
            </sec>
            <sec>
              <title>Results</title>
              <p>-Characteristics of the patients</p>
              <p>Among the 31 patients with cGVHD complaining of xerostomia, 28 met the inclusion criteria (Fig. <xref ref-type="fig" rid="F1">1</xref>). They were randomly assigned to two groups: group A (n=14, malic acid 1%) and group B (n=14, placebo). <xref rid="T2" ref-type="table"> Table 2</xref> shows intervention group versus control group results in relation to age, gender, DMQ scores and unstimulated salivary flow rate.</p>
              <p>
                <fig id="F1" orientation="portrait" position="float">
                  <label>Figure 1</label>
                  <caption>
                    <p>Enrollment flow chart.</p>
                  </caption>
                  <graphic xlink:href="medoral-24-e190-g001"/>
                </fig>
              </p>
              <p>
                <table-wrap id="T2" orientation="portrait" position="float">
                  <label>Table 2</label>
                  <caption>
                    <title>Demographic characteristics of the two groups, DMQ scores and unstimulated salivary flow rate.</title>
                  </caption>
                  <graphic xlink:href="medoral-24-e190-t002"/>
                </table-wrap>
              </p>
              <p>There were no statistically significant differences (<italic>p</italic>&gt;0.05) between the demographic characteristics of the two groups; therefore, the two groups were homogeneous.</p>
              <p>-DMQ scores</p>
              <p>DMQ scores increased significantly from 1.3 ± 0.4 to 3.5 ± 0.4 points (<italic>p</italic>&lt;0.05) after the two weeks treatment with malic acid, whereas in the control group DMQ scores increased from 1.2 ± 0.7 points to 1.4 ± 0.6 (<italic>p</italic>&gt;0.05).</p>
              <p>-Unstimulated salivary flow rate</p>
              <p>After two weeks of treatment, the unstimulated salivary flow rate increased significantly from 0.15 ± 0.06 mL/min to 0.24± 0.08 mL/min whereas that of the patients treated with placebo went from 0.16 ± 0.07 mL/min to 0.17 ± 0.09 mL/min (<italic>p</italic>&gt;0.05).</p>
            </sec>
            <sec>
              <title>Discussion</title>
              <p>Xerostomia, i.e. the subjective sensation of a dry mouth, can be either caused by a hypofunction of the salivary glands (reduced volume of saliva secretion) or by a change in salivary composition. Dry mouth is usually associated with difficulty in swallowing, speaking and numerous other oral health problems. Since 1989 (<xref rid="B14" ref-type="bibr">14</xref>), the salivary glands have been recognized as a very sensitive target for cGVHD. Reduction in whole saliva flow rate in GVHD patients has been reported in many studies, as well as various salivary biochemical and immunologic compositional alterations. The mechanism of salivary involvement depends on the lymphocyte infiltration, mostly T cells with a predominance of CD8+ over CD4+, in the glandular parenchyma, especially around the secretor ducts.</p>
              <p>Such periductal infiltration associated with a cytokine dysregulation (especially IL-2, IL-6, IFNgamma, TNF alfa) are considered responsible for the salivary parenchymal atrophy and hypofunction (<xref rid="B7" ref-type="bibr">7</xref>,<xref rid="B15" ref-type="bibr">15</xref>).</p>
              <p>This study was carried out on patients with cGVHD complaining of xerostomia. Xerostomia is defined as the subjective complaint of dry mouth. Objective presentation of salivary gland hypofunction does not necessarily reflect a subjective perception of xerostomia and vice versa. Interestingly, patients complaining of xerostomia frequently do not show any objective sign of hypo-salivation and their symptoms may be secondary to qualitative and/or quantitative changes in the composition of saliva. The content and production of saliva by different salivary glands display circadian variations affecting different aspects of symptoms related to salivary dysfunction (<xref rid="B16" ref-type="bibr">16</xref>,<xref rid="B17" ref-type="bibr">17</xref>).</p>
              <p>Xerostomia in patients with objective hypo-salivation is diagnosed when the rate of saliva flow is less than the rate of fluid absorption across the oral mucosa plus the rate of fluid evaporation from the mouth (<xref rid="B17" ref-type="bibr">17</xref>,<xref rid="B18" ref-type="bibr">18</xref>).</p>
              <p>The normal unstimulated salivary flow rate is approximately 0.3–0.4 mL/min (<xref rid="B17" ref-type="bibr">17</xref>,<xref rid="B19" ref-type="bibr">19</xref>-<xref rid="B20" ref-type="bibr">20</xref>).</p>
              <p>A diagnosis of hypo-salivation is made when the unstimulated salivary flow rate is around 0.1 mL/min (<xref rid="B17" ref-type="bibr">17</xref>,<xref rid="B20" ref-type="bibr">20</xref>-<xref rid="B21" ref-type="bibr">21</xref>). Our patients had a baseline salivary flow rate ranging from 0.09 to 0.26 mL/min, thus patients with a subjective sensation of xerostomia and those with a hypo-salivation were included.</p>
              <p>Although no standard treatment guidelines are available, many treatment options exist for the management of xerostomia in cGVHD. Several treatment strategies have been recommended in the past years and they all aim to reduce patients’ symptoms and/or increase salivary flow. Pilocarpine and cevimeline are two systemic US Food and Drug Administration-approved sialogogues. They are effective, but they have many side effects i.e. excessive sweating, cutaneous vasodilatation, emesis, nausea, diarrhea, persistent hiccup, bronchoconstriction, hypotension, bradycardia, increased urinary frequency, and vision problems (<xref rid="B17" ref-type="bibr">17</xref>,<xref rid="B22" ref-type="bibr">22</xref>).</p>
              <p>Easy remedies are proper hydration, increase in humidity at night-time, avoidance of irritating dentifrices and crunchy/hard foods and use of sugar-free chewing gums/candy.</p>
              <p>Currently, intraoral topical agents are among the most commonly recommended treatments for the management of xerostomia. These include saliva stimulants and substitutes (<xref rid="B23" ref-type="bibr">23</xref>).</p>
              <p>Saliva substitutes aim to increase viscosity and mimic natural saliva without altering the salivary flow. They contain minerals (eg, fluoride, calcium, and phosphate ions), carboxymethylcellulose or hydroxyethylcellulose, flavoring agents, and preservatives (eg, propyl or methyl paraben). Other remedies include mucoadhesive lipid-based bioerodible tablets or mucin sprays, although their efficacy for management of xerostomia remains controversial (<xref rid="B17" ref-type="bibr">17</xref>,<xref rid="B23" ref-type="bibr">23</xref>).</p>
              <p>This study aimed to evaluate the effectiveness of a topical sialogogue spray containing malic acid 1% in patients (Salivaktive®) in patients with cGVHD experiencing xerostomia. The application of topical sialogogues containing acids in the treatment of xerostomia isn’t new. However, continuous application of substances such as citric acid has been related to an increased risk of caries, due to the erosive action of these agents on dentin (<xref rid="B24" ref-type="bibr">24</xref>,<xref rid="B25" ref-type="bibr">25</xref>).</p>
              <p>All these products were dropped because of their demineralising effect on human dentin, effect not only caused by the high doses of acidic products, but also by how the product consumption (chewable products), as some allow for a lengthy contact with the dental surfaces. Products in a spray format allow for a fast and direct contact with the oral mucosa, and this, if combined with a suitable concentration (as the stimulant effect on saliva production is not altered by it), could reduce the demineralising potential of these substances.</p>
              <p>Malic acid acts as a sour tasting gustatory stimulus. Its mechanism of action is linked to dissociation of H+ in malic acid in water, which becomes hydronium ions (H3O+); this action generates a stimulation of salivary secretion to dilute the concentration of acids in the oral cavity. Xylitol do not stimulate saliva but it reduces erosion and cariogenic potential. Thus, a spray containing malic acid with xylitol seems to be a safe topical sialogogue (<xref rid="B26" ref-type="bibr">26</xref>,<xref rid="B27" ref-type="bibr">27</xref>).</p>
              <p>DMQ was used as it is an easy and fast method to assess the efficacy of topical sialogogues. In addition to this, its 0-to-4 scale can be easily replaced by a Visual Analogue Scale (VAS) of 10 cm. According to DMQ scores, feelings of oral dryness among intervention group improved significantly in comparison with the control group. The results also showed an increase of the unstimulated salivary flow rate, after the use of 1% malic acid spray for 2 weeks. According to the results of our study, the use of malic acid as a salivary stimulant can be a valid option for the treatment of cGVHD-induced xerostomia.</p>
            </sec>
          </body>
          <back>
            <ref-list>
              <ref id="B1">
                <label>1</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Travnik</surname>
                      <given-names>R</given-names>
                    </name>
                    <name>
                      <surname>Beckers</surname>
                      <given-names>M</given-names>
                    </name>
                    <name>
                      <surname>Wolff</surname>
                      <given-names>D</given-names>
                    </name>
                    <name>
                      <surname>Holler</surname>
                      <given-names>E</given-names>
                    </name>
                    <name>
                      <surname>Landthaler</surname>
                      <given-names>M</given-names>
                    </name>
                    <name>
                      <surname>Karrer</surname>
                      <given-names>S</given-names>
                    </name>
                  </person-group>
                  <article-title>Graft-versus-Host Disease (GvHD) - an update. Part 1: Pathophysiology, clinical features and classification of GvHD</article-title>
                  <source>Hautarzt</source>
                  <year>2011</year>
                  <volume>62</volume>
                  <fpage>139</fpage>
                  <lpage>54</lpage>
                  <?supplied-pmid 21279310?>
                  <pub-id pub-id-type="pmid">21279310</pub-id>
                </element-citation>
              </ref>
              <ref id="B2">
                <label>2</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Margaix-Muñoz</surname>
                      <given-names>M</given-names>
                    </name>
                    <name>
                      <surname>Bagán</surname>
                      <given-names>JV</given-names>
                    </name>
                    <name>
                      <surname>Jiménez</surname>
                      <given-names>Y</given-names>
                    </name>
                    <name>
                      <surname>Sarrión</surname>
                      <given-names>MG</given-names>
                    </name>
                    <name>
                      <surname>Poveda-Roda</surname>
                      <given-names>R</given-names>
                    </name>
                  </person-group>
                  <article-title>Graft-versus-host disease affecting oral cavity. A review</article-title>
                  <source>J Clin Exp Dent</source>
                  <year>2015</year>
                  <volume>7</volume>
                  <fpage>138</fpage>
                  <lpage>45</lpage>
                  <?supplied-pmid 25810826?>
                  <pub-id pub-id-type="pmid">25810826</pub-id>
                </element-citation>
              </ref>
              <ref id="B3">
                <label>3</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Filipovich</surname>
                      <given-names>AH</given-names>
                    </name>
                    <name>
                      <surname>Weisdorf</surname>
                      <given-names>D</given-names>
                    </name>
                    <name>
                      <surname>Pavletic</surname>
                      <given-names>S</given-names>
                    </name>
                    <name>
                      <surname>Socie</surname>
                      <given-names>G</given-names>
                    </name>
                    <name>
                      <surname>Wingard</surname>
                      <given-names>JR</given-names>
                    </name>
                    <name>
                      <surname>Lee</surname>
                      <given-names>SJ</given-names>
                    </name>
                  </person-group>
                  <article-title>National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and staging working group report</article-title>
                  <source>Biol Blood Marrow Transplant</source>
                  <year>2005</year>
                  <volume>11</volume>
                  <fpage>945</fpage>
                  <lpage>56</lpage>
                  <?supplied-pmid 16338616?>
                  <pub-id pub-id-type="pmid">16338616</pub-id>
                </element-citation>
              </ref>
              <ref id="B4">
                <label>4</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Mays</surname>
                      <given-names>JW</given-names>
                    </name>
                    <name>
                      <surname>Fassil</surname>
                      <given-names>H</given-names>
                    </name>
                    <name>
                      <surname>Edwards</surname>
                      <given-names>DA</given-names>
                    </name>
                    <name>
                      <surname>Pavletic</surname>
                      <given-names>SZ</given-names>
                    </name>
                    <name>
                      <surname>Bassim</surname>
                      <given-names>CW</given-names>
                    </name>
                  </person-group>
                  <article-title>Oral chronic graft-versus-host disease: current pathogenesis, therapy, and research</article-title>
                  <source>Oral Dis</source>
                  <year>2013</year>
                  <volume>19</volume>
                  <fpage>327</fpage>
                  <lpage>46</lpage>
                  <?supplied-pmid 23107104?>
                  <pub-id pub-id-type="pmid">23107104</pub-id>
                </element-citation>
              </ref>
              <ref id="B5">
                <label>5</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Treister</surname>
                      <given-names>NS</given-names>
                    </name>
                    <name>
                      <surname>Cook</surname>
                      <given-names>EF Jr</given-names>
                    </name>
                    <name>
                      <surname>Antin</surname>
                      <given-names>J</given-names>
                    </name>
                    <name>
                      <surname>Lee</surname>
                      <given-names>SJ</given-names>
                    </name>
                    <name>
                      <surname>Soiffer</surname>
                      <given-names>R</given-names>
                    </name>
                    <name>
                      <surname>Woo</surname>
                      <given-names>SB</given-names>
                    </name>
                  </person-group>
                  <article-title>Clinical evaluation of oral chronic graft-versus-host disease</article-title>
                  <source>Biol Blood Marrow Transplant</source>
                  <year>2008</year>
                  <volume>14</volume>
                  <fpage>110</fpage>
                  <lpage>5</lpage>
                  <?supplied-pmid 18158967?>
                  <pub-id pub-id-type="pmid">18158967</pub-id>
                </element-citation>
              </ref>
              <ref id="B6">
                <label>6</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Imanguli</surname>
                      <given-names>MM</given-names>
                    </name>
                    <name>
                      <surname>Atkinson</surname>
                      <given-names>JC</given-names>
                    </name>
                    <name>
                      <surname>Harvey</surname>
                      <given-names>KE</given-names>
                    </name>
                    <name>
                      <surname>Hoehn</surname>
                      <given-names>GT</given-names>
                    </name>
                    <name>
                      <surname>Ryu</surname>
                      <given-names>OH</given-names>
                    </name>
                    <name>
                      <surname>Wu</surname>
                      <given-names>T</given-names>
                    </name>
                  </person-group>
                  <article-title>Changes in salivary proteome following allogeneic hematopoietic stem cell transplantation</article-title>
                  <source>Exp Hematol</source>
                  <year>2007</year>
                  <volume>35</volume>
                  <fpage>184</fpage>
                  <lpage>92</lpage>
                  <?supplied-pmid 17258067?>
                  <pub-id pub-id-type="pmid">17258067</pub-id>
                </element-citation>
              </ref>
              <ref id="B7">
                <label>7</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Nagler</surname>
                      <given-names>RM</given-names>
                    </name>
                    <name>
                      <surname>Nagler</surname>
                      <given-names>A</given-names>
                    </name>
                  </person-group>
                  <article-title>Salivary gland involvement in graft-versus-host disease: the underlying mechanism and implicated treatment</article-title>
                  <source>Isr Med Assoc J</source>
                  <year>2004</year>
                  <volume>6</volume>
                  <fpage>167</fpage>
                  <lpage>72</lpage>
                  <?supplied-pmid 15055275?>
                  <pub-id pub-id-type="pmid">15055275</pub-id>
                </element-citation>
              </ref>
              <ref id="B8">
                <label>8</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Imanguli</surname>
                      <given-names>MM</given-names>
                    </name>
                    <name>
                      <surname>Atkinson</surname>
                      <given-names>JC</given-names>
                    </name>
                    <name>
                      <surname>Mitchell</surname>
                      <given-names>SA</given-names>
                    </name>
                    <name>
                      <surname>Avila</surname>
                      <given-names>DN</given-names>
                    </name>
                    <name>
                      <surname>Bishop</surname>
                      <given-names>RJ</given-names>
                    </name>
                    <name>
                      <surname>Cowen</surname>
                      <given-names>EW</given-names>
                    </name>
                  </person-group>
                  <article-title>Salivary gland involvement in chronic graft-versus-host disease: prevalence, clinical significance, and recommendations for evaluation</article-title>
                  <source>Biol Blood Marrow Transplant</source>
                  <year>2010</year>
                  <volume>16</volume>
                  <fpage>1362</fpage>
                  <lpage>9</lpage>
                  <?supplied-pmid 20353829?>
                  <pub-id pub-id-type="pmid">20353829</pub-id>
                </element-citation>
              </ref>
              <ref id="B9">
                <label>9</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Vissink</surname>
                      <given-names>A</given-names>
                    </name>
                    <name>
                      <surname>Schaub</surname>
                      <given-names>RM</given-names>
                    </name>
                    <name>
                      <surname>van Rijn</surname>
                      <given-names>LJ</given-names>
                    </name>
                    <name>
                      <surname>Gravenmade</surname>
                      <given-names>EJ</given-names>
                    </name>
                    <name>
                      <surname>Panders</surname>
                      <given-names>AK</given-names>
                    </name>
                    <name>
                      <surname>Vermey</surname>
                      <given-names>A</given-names>
                    </name>
                  </person-group>
                  <article-title>The efficacy of mucin-containing artificial saliva in alleviating symptoms of xerostomia</article-title>
                  <source>Gerodontology</source>
                  <year>1987</year>
                  <volume>6</volume>
                  <fpage>95</fpage>
                  <lpage>101</lpage>
                  <?supplied-pmid 3505496?>
                  <pub-id pub-id-type="pmid">3505496</pub-id>
                </element-citation>
              </ref>
              <ref id="B10">
                <label>10</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Gravenmade</surname>
                      <given-names>EJ</given-names>
                    </name>
                    <name>
                      <surname>Vissink</surname>
                      <given-names>A</given-names>
                    </name>
                  </person-group>
                  <article-title>Mucin-containing lozenges in the treatment of intraoral problems associated with Sjögren's syndrome. A double-blind crossover study in 42 patients</article-title>
                  <source>Oral Surg Oral Med Oral Pathol</source>
                  <year>1993</year>
                  <volume>75</volume>
                  <fpage>466</fpage>
                  <lpage>71</lpage>
                  <?supplied-pmid 8464611?>
                  <pub-id pub-id-type="pmid">8464611</pub-id>
                </element-citation>
              </ref>
              <ref id="B11">
                <label>11</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>van der Reijden</surname>
                      <given-names>WA</given-names>
                    </name>
                    <name>
                      <surname>van der Kwaak</surname>
                      <given-names>H</given-names>
                    </name>
                    <name>
                      <surname>Vissink</surname>
                      <given-names>A</given-names>
                    </name>
                    <name>
                      <surname>Veerman</surname>
                      <given-names>EC</given-names>
                    </name>
                    <name>
                      <surname>Amerongen</surname>
                      <given-names>AV</given-names>
                    </name>
                  </person-group>
                  <article-title>Treatment of xerostomia with polymer-based saliva substitutes in patients with Sjögren's syndrome</article-title>
                  <source>Arthritis Rheum</source>
                  <year>1996</year>
                  <volume>39</volume>
                  <fpage>57</fpage>
                  <lpage>63</lpage>
                  <?supplied-pmid 8546739?>
                  <pub-id pub-id-type="pmid">8546739</pub-id>
                </element-citation>
              </ref>
              <ref id="B12">
                <label>12</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Regelink</surname>
                      <given-names>G</given-names>
                    </name>
                    <name>
                      <surname>Vissink</surname>
                      <given-names>A</given-names>
                    </name>
                    <name>
                      <surname>Reintsema</surname>
                      <given-names>H</given-names>
                    </name>
                    <name>
                      <surname>Nauta</surname>
                      <given-names>JM</given-names>
                    </name>
                  </person-group>
                  <article-title>Efficacy of a synthetic polymer saliva substitute in reducing oral complaints of patients suffering from irradiation-induced xerostomia</article-title>
                  <source>Quintessence Int</source>
                  <year>1998</year>
                  <volume>29</volume>
                  <fpage>383</fpage>
                  <lpage>8</lpage>
                  <?supplied-pmid 9728149?>
                  <pub-id pub-id-type="pmid">9728149</pub-id>
                </element-citation>
              </ref>
              <ref id="B13">
                <label>13</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Navazesh</surname>
                      <given-names>M</given-names>
                    </name>
                    <name>
                      <surname>Christensen</surname>
                      <given-names>CM</given-names>
                    </name>
                  </person-group>
                  <article-title>A comparison of whole mouth resting and stimulated salivary measurement procedures</article-title>
                  <source>J Dent Res</source>
                  <year>1982</year>
                  <volume>61</volume>
                  <fpage>1158</fpage>
                  <lpage>62</lpage>
                  <?supplied-pmid 6956596?>
                  <pub-id pub-id-type="pmid">6956596</pub-id>
                </element-citation>
              </ref>
              <ref id="B14">
                <label>14</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Nakhleh</surname>
                      <given-names>RE</given-names>
                    </name>
                    <name>
                      <surname>Miller</surname>
                      <given-names>W</given-names>
                    </name>
                    <name>
                      <surname>Snover</surname>
                      <given-names>DC</given-names>
                    </name>
                  </person-group>
                  <article-title>Significance of mucosal vs salivary gland changes in lip biopsies in the diagnosis of chronic graft-vs-host disease</article-title>
                  <source>Arch Pathol Lab Med</source>
                  <year>1989</year>
                  <volume>113</volume>
                  <fpage>932</fpage>
                  <lpage>4</lpage>
                  <?supplied-pmid 2757495?>
                  <pub-id pub-id-type="pmid">2757495</pub-id>
                </element-citation>
              </ref>
              <ref id="B15">
                <label>15</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Nagler</surname>
                      <given-names>RM</given-names>
                    </name>
                    <name>
                      <surname>Nagler</surname>
                      <given-names>A</given-names>
                    </name>
                  </person-group>
                  <article-title>Major salivary gland involvement in graft-versus-host disease: considerations related to pathogenesis, the role of cytokines and therapy</article-title>
                  <source>Cytokines Cell Mol Ther</source>
                  <year>1999</year>
                  <volume>5</volume>
                  <fpage>227</fpage>
                  <lpage>32</lpage>
                  <?supplied-pmid 10850387?>
                  <pub-id pub-id-type="pmid">10850387</pub-id>
                </element-citation>
              </ref>
              <ref id="B16">
                <label>16</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Van der Putten</surname>
                      <given-names>GJ</given-names>
                    </name>
                    <name>
                      <surname>Brand</surname>
                      <given-names>HS</given-names>
                    </name>
                    <name>
                      <surname>Schols</surname>
                      <given-names>JM</given-names>
                    </name>
                    <name>
                      <surname>de Baat</surname>
                      <given-names>C</given-names>
                    </name>
                  </person-group>
                  <article-title>The diagnostic suitability of a xerostomia questionnaire and the association between xerostomia, hyposalivation and medication use in a group of nursing home residents</article-title>
                  <source>Clin Oral Investig</source>
                  <year>2011</year>
                  <volume>15</volume>
                  <fpage>185</fpage>
                  <lpage>92</lpage>
                  <?supplied-pmid 20165967?>
                  <pub-id pub-id-type="pmid">20165967</pub-id>
                </element-citation>
              </ref>
              <ref id="B17">
                <label>17</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Villa</surname>
                      <given-names>A</given-names>
                    </name>
                    <name>
                      <surname>Connel</surname>
                      <given-names>CL</given-names>
                    </name>
                    <name>
                      <surname>Abati</surname>
                      <given-names>S</given-names>
                    </name>
                  </person-group>
                  <article-title>Diagnosis and management of xerostomia and hyposalivation</article-title>
                  <source>Ther Clin Risk Manag</source>
                  <year>2015</year>
                  <volume>11</volume>
                  <fpage>45</fpage>
                  <lpage>51</lpage>
                  <?supplied-pmid 25653532?>
                  <pub-id pub-id-type="pmid">25653532</pub-id>
                </element-citation>
              </ref>
              <ref id="B18">
                <label>18</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Dawes</surname>
                      <given-names>C</given-names>
                    </name>
                  </person-group>
                  <article-title>How much saliva is enough for avoidance of xerostomia?</article-title>
                  <source>Caries Res</source>
                  <year>2004</year>
                  <volume>38</volume>
                  <fpage>236</fpage>
                  <lpage>40</lpage>
                  <?supplied-pmid 15153694?>
                  <pub-id pub-id-type="pmid">15153694</pub-id>
                </element-citation>
              </ref>
              <ref id="B19">
                <label>19</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Humphrey</surname>
                      <given-names>SP</given-names>
                    </name>
                    <name>
                      <surname>Williamson</surname>
                      <given-names>RT</given-names>
                    </name>
                  </person-group>
                  <article-title>A review of saliva: normal composition, flow and function</article-title>
                  <source>J Prosthet Dent</source>
                  <year>2001</year>
                  <volume>85</volume>
                  <fpage>162</fpage>
                  <lpage>9</lpage>
                  <?supplied-pmid 11208206?>
                  <pub-id pub-id-type="pmid">11208206</pub-id>
                </element-citation>
              </ref>
              <ref id="B20">
                <label>20</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Pedersen</surname>
                      <given-names>AM</given-names>
                    </name>
                    <name>
                      <surname>Bardow</surname>
                      <given-names>A</given-names>
                    </name>
                    <name>
                      <surname>Jensen</surname>
                      <given-names>SB</given-names>
                    </name>
                    <name>
                      <surname>Nauntofte</surname>
                      <given-names>B</given-names>
                    </name>
                  </person-group>
                  <article-title>Saliva and gastrointestinal functions of taste, mastication, swallowing and digestion</article-title>
                  <source>Oral Dis</source>
                  <year>2002</year>
                  <volume>8</volume>
                  <fpage>117</fpage>
                  <lpage>29</lpage>
                  <?supplied-pmid 12108756?>
                  <pub-id pub-id-type="pmid">12108756</pub-id>
                </element-citation>
              </ref>
              <ref id="B21">
                <label>21</label>
                <element-citation publication-type="book">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Sreebny</surname>
                      <given-names>LM</given-names>
                    </name>
                    <name>
                      <surname>Vissink</surname>
                      <given-names>A</given-names>
                    </name>
                  </person-group>
                  <source>Dry Mouth: the malevolent symptom. A clinical guide</source>
                  <year>2010</year>
                  <publisher-name>Ames: Wiley-Blackwell</publisher-name>
                </element-citation>
              </ref>
              <ref id="B22">
                <label>22</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Watanabe</surname>
                      <given-names>M</given-names>
                    </name>
                    <name>
                      <surname>Yamada</surname>
                      <given-names>C</given-names>
                    </name>
                    <name>
                      <surname>Komagata</surname>
                      <given-names>Y</given-names>
                    </name>
                    <name>
                      <surname>Kikuchi</surname>
                      <given-names>H</given-names>
                    </name>
                    <name>
                      <surname>Hosono</surname>
                      <given-names>H</given-names>
                    </name>
                    <name>
                      <surname>Itagaki</surname>
                      <given-names>F</given-names>
                    </name>
                  </person-group>
                  <article-title>New low-dose liquid pilocarpine formulation for treating dry mouth in Sjögren's syndrome: clinical efficacy, symptom relief, and improvement in quality of life</article-title>
                  <source>J Pharm Health Care Sci</source>
                  <year>2018</year>
                  <volume>4</volume>
                  <fpage>4</fpage>
                  <?supplied-pmid 29507747?>
                  <pub-id pub-id-type="pmid">29507747</pub-id>
                </element-citation>
              </ref>
              <ref id="B23">
                <label>23</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Visvanathan</surname>
                      <given-names>V</given-names>
                    </name>
                    <name>
                      <surname>Nix</surname>
                      <given-names>P</given-names>
                    </name>
                  </person-group>
                  <article-title>Managing the patient presenting with xerostomia: a review</article-title>
                  <source>Int J Clin Pract</source>
                  <year>2010</year>
                  <volume>64</volume>
                  <fpage>404</fpage>
                  <lpage>7</lpage>
                  <?supplied-pmid 19817913?>
                  <pub-id pub-id-type="pmid">19817913</pub-id>
                </element-citation>
              </ref>
              <ref id="B24">
                <label>24</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Gambon</surname>
                      <given-names>DL</given-names>
                    </name>
                    <name>
                      <surname>Brand</surname>
                      <given-names>HS</given-names>
                    </name>
                    <name>
                      <surname>Nieuw Amerongen</surname>
                      <given-names>AV</given-names>
                    </name>
                  </person-group>
                  <article-title>The erosive potential of candy sprays</article-title>
                  <source>Br Dent J</source>
                  <year>2009</year>
                  <volume>206</volume>
                  <fpage>530</fpage>
                  <lpage>1</lpage>
                  <?supplied-pmid 19404272?>
                  <pub-id pub-id-type="pmid">19404272</pub-id>
                </element-citation>
              </ref>
              <ref id="B25">
                <label>25</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Gómez-Moreno</surname>
                      <given-names>G</given-names>
                    </name>
                    <name>
                      <surname>Guardia</surname>
                      <given-names>J</given-names>
                    </name>
                    <name>
                      <surname>Aguilar-Salvatierra</surname>
                      <given-names>A</given-names>
                    </name>
                    <name>
                      <surname>Cabrera-Ayala</surname>
                      <given-names>M</given-names>
                    </name>
                    <name>
                      <surname>Maté-Sánchez de-Val</surname>
                      <given-names>JE</given-names>
                    </name>
                    <name>
                      <surname>Calvo-Guirado</surname>
                      <given-names>JL</given-names>
                    </name>
                  </person-group>
                  <article-title>Effectiveness of malic acid 1% in patients with xerostomia induced by antihypertensive drugs</article-title>
                  <source>Med Oral Patol Oral Cir Bucal</source>
                  <year>2013</year>
                  <volume>18</volume>
                  <fpage>49</fpage>
                  <lpage>55</lpage>
                  <?supplied-pmid 22926481?>
                  <pub-id pub-id-type="pmid">22926481</pub-id>
                </element-citation>
              </ref>
              <ref id="B26">
                <label>26</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>da Mata</surname>
                      <given-names>AD</given-names>
                    </name>
                    <name>
                      <surname>da Silva Marques</surname>
                      <given-names>DN</given-names>
                    </name>
                    <name>
                      <surname>Silveira</surname>
                      <given-names>JM</given-names>
                    </name>
                    <name>
                      <surname>Marques</surname>
                      <given-names>JR</given-names>
                    </name>
                    <name>
                      <surname>de Melo Campos Felino</surname>
                      <given-names>ET</given-names>
                    </name>
                    <name>
                      <surname>Guilherme</surname>
                      <given-names>NF</given-names>
                    </name>
                  </person-group>
                  <article-title>Effects of gustatory stimulants of salivary secretion on salivary pH and flow: a randomized controlled trial</article-title>
                  <source>Oral Dis</source>
                  <year>2009</year>
                  <volume>15</volume>
                  <fpage>220</fpage>
                  <lpage>8</lpage>
                  <?supplied-pmid 19220764?>
                  <pub-id pub-id-type="pmid">19220764</pub-id>
                </element-citation>
              </ref>
              <ref id="B27">
                <label>27</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Martín-Piedra</surname>
                      <given-names>MA</given-names>
                    </name>
                    <name>
                      <surname>Gómez-Moreno</surname>
                      <given-names>G</given-names>
                    </name>
                    <name>
                      <surname>Herrera</surname>
                      <given-names>D</given-names>
                    </name>
                    <name>
                      <surname>Aguilar-Salvatierra</surname>
                      <given-names>A</given-names>
                    </name>
                  </person-group>
                  <article-title>Effectiveness of a recent topical sialogogue in the management of drug-induced xerostomia</article-title>
                  <source>J Clin Exp Dent</source>
                  <year>2011</year>
                  <volume>3</volume>
                  <fpage>268</fpage>
                  <lpage>73</lpage>
                </element-citation>
              </ref>
            </ref-list>
          </back>
        </article>
      </metadata>
    </record>
  </GetRecord>
</OAI-PMH>
